January 30, 2019
Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients
Read More
January 30, 2019
Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3
Read More
January 30, 2019
Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3
Read More
January 30, 2019
IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1
Read More
January 30, 2019
IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1
Read More
January 30, 2019
SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C
Read More
January 30, 2019
SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C
Read More
January 30, 2019
Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin
Read More
January 30, 2019
Study of Daclatasvir (BMS-790052) Add-on to Standard of Care in Treatment- naïve Patients
Read More
January 30, 2019
Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives)
Read More
January 30, 2019
Clinical Trial for Non-responders Who Previously Participated in Eltrombopag Studies TPL 103922 or TPL 108390
Read More
January 30, 2019
Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Immunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4)
Read More
Load More
X